Choledochal Cyst (CDC)

1. Introduction

Choledochal cyst (CDC) is the congenital dilatation of the bile ducts. The condition is a relatively rare abnormality with an estimated incidence of 1 in 13,000–15,000 in Western populations. However, this condition is far more common in the East, with an incidence of 1 per 1000 in Japan [1, 2]. The etiology remains unknown, but choledochal cysts are likely to be congenital in nature. Other proposed theories include distal obstruction, Abnormal Pancreatico-biliary Duct Junction (APBDJ), sphnictor oddi dysfunction. The pathologic features of the CDC frequently include an anomalous junction of the pancreatic and common bile ducts pancreaticobiliary malunion (PBMU), intrahepatic bile duct dilatation, and various degrees of hepatic fibrosis. Anatomically choledochal cysts are usually classified into three groups. However, based on the cholangiographic findings of intrahepatic ducts or pancreaticobiliary malunion (PBMU), the so-called long common channel, other forms and subgroups have been described. Left untreated, choledochal cysts can undergo malignant transformation and promote progressive hepatic fibrosis. About 20% case present during adulthood [3]. The gallbladder or bile duct malignancy has been reported as 6–20% and 15–20% in the United States and Japan, respectively [4, 5]. Therefore, treatment includes complete excision of the cysts with Roux-en-Y hepatojejunostomy and close surveillance.

2. Aetiopathogenesis

The etiology of choledochal cystic disease remains ill-defined; however, these malformations are considered congenital because they occur in fetuses and in newborns. The most commonly accepted theory for choledochal cysts is based on the observation that they are frequently associated with an anomalous pancreatobiliary duct junction (APBDJ). The “long common channel theory” explained that APBDJ allows reflux of pancreatic enzymes into the common bile duct. The reflux of pancreatic juice results in dissolution of the ductal wall and obstruction at distal end of cyst due to edema/fibrosis [6].

Another theory proposed that this disease results from derangement in normal embryologic remodeling of ducts and causes varying degrees of destructive inflammation and segmental dilatation [7, 8]. Kusunoki et al. demonstrated suboptimal number of ganglion cells in the narrow portion if the common bile duct in patients with a choledochal cyst, as compared with controls [9, 10]. Based on an experimental study in which cystic dilatation of the common bile duct was produced by ligation of the distal end of the common bile duct in the neonatal lamb, an obstructive factor in the early developmental stage was described as a causative factor.

APBJ is defined as a junction between the pancreatic and bile ducts and is located outside of the duodenal wall [11]. Babbitt analyzed that most choledochal cysts were complicated by APBJ [12]. APBJ is classified into two types (P-C and C-P type) by analyzing the fusion pattern between the pancreatic and bile ducts. In the P-C type, the main pancreatic duct joins the common bile duct, while the common bile duct appears to join the main pancreatic duct in the C-P type [13].

In 1991, Komi et al. classified APBJ into three groups type I, II, and III according to the running of the accessory pancreatic duct and dilatation of the common channel Types I and II correspond to the C-P type, P-C type and type III was named as complex type of APBJ [14]. The incidence of type I, II, and III APBJ was 35.3, 21.6, 43.1%, respectively (Figures 1 and 2).

In 2003, Tashiro et al. analyzed 1627 patients of CDC and found patients with APBJ overlapped with that in normal cases. Furthermore, reflux of the pancreatic juice was reported in patients without APBDJ. Considering the conditions similar to APBJ, APBJ should be defined as when the long common channel with out any relation to sphincter of Oddi contraction [15].

3. Classification of choledochal cyst

Based on the site of cystic changes five types of CDC have been described by Todani and colleagues Type I–V(Figure 2). Type Iconstitutes about 50–80% of all CDC, Type II(2%), Type III(1.4–4%), Type IV (15–35% of all CC) and Type Vor Caroli’s disease(20%) [16].

Type I cyststypically appear as anechoic cystic lesions, which communicate with the biliary tract. Type 1 is further divided into; (1A, 1B, or 1C). In type IA, the gallbladder arises from the choledochal cyst and a dilated extrahepatic biliary tree is seen while the intrahepatic ducts are normal in size and appearance. Type IB an isolated dilatation of the most distal aspect of the CBD. In Type 1C a smooth fusiform dilatation of the common hepatic duct (CHD) and CBD is associated with pancreaticobiliary malunion.

Type II cystsare diverticula of CBD which appear as anechoic cyst juxtaposed to CBD with CHD. Type II cysts appear as anechoic cysts juxtaposed to the CBD with a normal appearing gallbladder and CHD. Cholangiography demonstrates opacification of a true diverticulum arising from the CBD7 and can resemble gallbladder duplication.

Type III cysts, or choledochoceles,comprise 1–4% of CC and are characterized by their intraduodenal location at the pancreaticobiliary junction. Type III cysts are also more likely to be diagnosed using ERCP and are associated with a much lower incidence of malignant transformation (2.5%). Additionally, APBD is less commonly seen in choledochoceles in comparison with other types of CDC.

Type IV CDCcan include both intrahepatic and extra-hepatic duct involvement. Type IVA CDC dilatation extends from the CBD and CHD into the intrahepatic biliary tree. Type IVB CC consists of multiple dilations of the extrahepatic biliary tree. Finally, type V CC, or Caroli’s diseaseis the intrahepatic saccular or fusiform dilatation with no underlying obstruction or extrahepatic biliary tree involvement. Type V CDCs are at times associated with polycystic kidney disease, an autosomal recessive inherited condition associated with mutation in PKD1 gene [17]. Investigators note the different clinical courses, management, and complication rates of the 5 types of CC, thus have challenged the modified Todani classification.

Forme Fruste Choledochal Cyst (FFCC); FFCCis characterized by non-specific changes of bile duct mucosa such as mucosal ulceration/sloughing, fibrosis, and inflammatory cell infiltration. Patients with FFCC may be at a high risk for carcinogenesis in the extrahepatic bile duct. These changes are similar to that seen in cystic or fusiform type choledochal cysts [18].

Pathologic changes in the liver including portal fibrosis, central venous dilataion, parenchymal inflammation, and bile duct proliferation. Furthermore, fibrosis of cyst wall lined by columnar epithelium, lymphocytic infiltration and mucosal dysplasia is also seen. Histologic appearances in Type I (and sometimes type IV) CDC is lack biliary mucosa; type II CDC closely resemble gallbladder duplication. Type III cysts are lined by duodenal mucosa, while type V cysts can have extensive hepatic fibrosis [19]. In the walls of CC there is increasing rate of epithelial metaplasia and biliary intraepithelial neoplasia with advancing age. Although the incidence of malignancy at diagnosis of CDC increases with age at diagnosis, the risk of developing a future malignancy in an existing benign CDC during one’s remaining lifetime likely decreases with advancing age. Carcinogenesis is thought to occur via multistep genetic events where early K-ras and p53 mutations are seen in more than 60% of CC-related carcinomas, followed by a late occurring DPC-4 gene inactivation [20].

Gallbladder carcinoma is identified in 10–25% of CDC-related malignancies 5.10 Malignancy is most commonly associated with types I and IV cysts, while types II, III, and V CC have minimal neoplastic risk. Most reported cases of malignant transformation are cholangiocarcinoma. The presence of an APBDU is thought to play a role in carcinogenesis and hepatocellular damage due to reflux of pancreatic contents into the bile duct [21].

4. Clinical features

5. Imaging

6. Management

The surgical treatment of choledochal cystic disease has evolved and been refined over the past century. Aspiration and marsupialisation were the earliest forms of surgical therapy, the development of external biliary fistulae. Complete cyst excision and internal drainage by hepaticoduodenostomy (McWhorter in 1924) however, unacceptable mortality rates were encountered. Gross advocated internal drainage by choledochocystduodenostomy in 1933 because of unacceptably high risk of cyst excision at that time. Subsequent patient evaluation, however, revealed morbidity rates approaching 50%, primarily a result of cholangitis from duodenal reflux. The transection level of the common hepatic duct and currently, complete excision of a cyst with cholecystectomy and Roux-en-Y hepaticojejunostomy reconstruction (RYHJ) is the standard therapy in Types I and IV-A cysts [39]. Although the overall morbidity was diminished, the risk of malignant degeneration within the cystic remnant was recognized. Persistent, although markedly diminished episodes of cholangitis in RYHJ reconstructions led to the development of a valved jejunal interposition. No studies have independently confirmed the efficacy of valved intestinal conduits in the prevention of reflux-induced cholangitis. Pericystic inflammation may prevent safe complete-cyst excision. An internal approach, as described by Lilly, requires mucosectomy of the inner epithelial lining prior to reconstruction, but avoids the danger of a difficult posterior dissection.

7. Cyst excision

A laparotomy through a high transverse or oblique right upper quadrant incision gives excellent exposure. The appearance of the liver, spleen, and pancreas is noted. If the anatomy has not been clearly defined preoperatively, an intraoperative cholangiogram should be performed. Aspirated the bile from the cyst and send it for culture and measurement of amylase/lipase. With large cysts, dye should be injection directly into the lower end of the common bile duct and into the common hepatic duct using a butterfly needle. Direct injection into a large cyst may obscure filling of the distal duct, it is important to try to identify the junction of the pancreatic and bile ducts [35]. If the cyst is extremely inflamed and adhesions are very dense, mucosectomy of the cyst should be performed rather than full-thickness dissection to minimize the risk of injuring the surrounding structures such as portal vein and hepatic artery (Figure 3). Where the bile duct begins to narrow down inferiorly, it is dissected circumferentially and encircled. The distal common bile duct is dissected to just within the head of the pancreas and transected. Common channel should be cleared with combination of saline irrigation, balloon catheters and, when possible. Intraoperative endoscopy helps removing plugs. Distal bile duct stump is transfixed with an absorbable suture [36] (Figure 4).

After dissection of GB and cyst, the portal vein is exposed. At times the right hepatic artery crosses in front of the cyst and is adherent to its wall and in this situation right hepatic artery must be carefully freed and preserved. The common hepatic duct is divided at the level of the bifurcation, where it should appear healthy and well vascularised (Figure 5).

To allow a wider bilio-enteric anastomosis, left duct is incised 5–10 mm. Anastomosis to a narrow common hepatic duct should be avoided because of the long-term risk of stricture. The duodenojejunal flexure is identified and the Roux loop jejunum anastomosed at duct bifurcation using fine, interrupted, absorbable monofilament sutures (6/0 or 7/0 PDS) (Figure 6).

Dilatation of the peripheral portion of the IHBD is associated with late complications which include recurrent cholangitis, stone formation, and anastomotic stricture. Intrahepatic cystenterostomy, or balloon dilatation of the stenosis at the time of cyst excision are options for dilatation of IHD.

Type II cysts:Excision of the diverticulum and repair of the common bile duct is performed in type IIa satisfactory procedure for this rare variety of choledochal cyst.

Type III cysts:Large choledochoceles can be removed transduodenally. Sphincteroplasty or endoscopic sphincterotomy are the two options for smaller choledochoceles with no pancreatobiliary malunion.

Type V cysts:If multiple cysts are confined to one side of the liver, hepatic lobectomy may be curative. Recurrent cholangitis and stone formation are common if multiple cysts are distributed throughout the liver. Antibiotics and drainage procedures are helpful in such cases, but liver transplantation should be considered in progressive cases.

The prognosis of choledochal cyst is excellent if the diagnosis is made expediently prior to the development of irreversible liver disease or malignancy. The common late complications are cholangitis, obstructive jaundice, pancreatitis, stone formation, and portal hypertension [37]. Long-term outcomes after excision and hepaticojejunostomy reconstruction for choledochal cysts have been reported in different series. Most of these show that with standard treatment of excision and drainage, these patients will have no significant sequelae from this treatment.

The congenital hepatic fibrosis coexistent in patients with type V CCD, it predisposes patient to portal hypertension. The incidence of cholelithiasis due to bile stasis is around 37.5–74%. Hepatolithiasis is most often associated with type IV-A CCD and is related to the presence of membranous or septal stenosis [38]. Total cyst excision reduces the risk of malignancy. However, sporadic malignancy has been reported after the excision of cysts. Cholangiocarcinoma developing after total resection of choledochal cysts after 10 to 34 years has been previously reported [39].

Biliary tract malignant tumor were associated in 80 patients (9.9%); 40 had bile duct cancer (50.0%), 35 had gallbladder cancer (43.8%), 3 had periampullary cancer, synchronous gallbladder and bile duct cancer was found in 2 patients. With a median follow-up duration of 51.8 months, 26.3% had a recurrence [40].

Incidence of hepato-biliary cancer in TYPE I, TYPE III, Type Iva, unknown was reported to be 71,1.3, 22.5 and 5%. Significantly more patients classified with type IVa had bile duct cancer and significantly more patients classified with type I had gallbladder cancer (P = .03) [41].

In a review of 200 children who had cyst excision. Primary cyst excision was performed in 176, 19 had cyst excision converted from other biliary surgery. The mean follow-up period was 10.9 years. In 188 patients Roux-en-Y hepaticojejunostomy was performed, 11 had standard hepaticoduodenostomy, and one had a jejunal interposition hepaticojejunostomy. There was no operative mortality. Eighteen (9.0%) patients had complications including cholangitis choledochus calculi, pancreatitis, and small bowel obstruction. Fifteen of the 18 children required surgical interventions such as revision of the hepaticoenterostomy. There was no occurrence of malignancy [42].

8. Conclusion

CDC is a congenital anomaly of hepatobiliary ducts. Various theories have been proposed including congenital origin, APBDJ, and defects in canalization during embryogenesis. CDC has been divided into five types depending on location of cyst. Choledochal cysts can have variable presentations ranging from infantile Cholestasis to pain abdomen jaundice and abdominal lump in adults. MRCP is the main investigation for diagnosis early diagnosis and treatment avoids possible late complications of cholangitis, cirrhosis, hepaticolithiasis and spontaneous perforation. Excision of the cyst with Roux-N Y hepaticojejunostomy is the best approach.